Avadel’s stock falls 21% after disclosing new FDA request for experimental narcolepsy drug

Shares of Avadel Pharmaceuticals PLC AVDL, +133.64% tumbled 21.6% in premarket trading on Thursday after the company said in a securities filing that the Food and Drug Administration requested additio...